Intercept Pharmaceuticals, Inc.
ICPT
Revenue
88.79M
▲5.07M▲6.06%
3 Months ChangeAssets
393.16M
▼-91.47M▼-18.87%
3 Months ChangeLiabilities
321.32M
▼-95.77M▼-22.96%
3 Months ChangeFree Cash Flow
-20.13M
▲34.90M▲63.42%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-11-08
Form 8-K
ID: 0001104659-23-115782
2023-11-06
Form 10-Q
ID: 0001558370-23-017790
2023-09-26
Form 8-K
ID: 0001104659-23-103739
2023-08-02
Form 10-Q
ID: 0001558370-23-012896
2023-08-02
Form 8-K
ID: 0001104659-23-086579
2023-06-23
Form 8-K
ID: 0001104659-23-073996
2023-06-23
Form 8-K
ID: 0001104659-23-073909
2023-05-25
Form 8-K
ID: 0001104659-23-064615
2023-05-22
Form 8-K
ID: 0001104659-23-062810
2023-05-18
Form 8-K
ID: 0001104659-23-061967